Eledon Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Eledon Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2024.
  • Eledon Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$20.5M, a 83.2% decline year-over-year.
  • Eledon Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$56.2M, a 38.5% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$43M, a 51.4% increase from 2022.
  • Eledon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$88.4M, a 140% decline from 2021.
  • Eledon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$36.9M, a 99.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$56.2M -$20.5M -$9.31M -83.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$46.9M -$14.5M -$4.15M -40.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$42.8M -$10.9M +$241K +2.17% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-08-19
Q4 2023 -$43M -$10.3M +$48.4M +82.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$91.4M -$11.2M -$600K -5.66% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$90.8M -$10.4M -$1.07M -11.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$89.7M -$11.1M -$1.25M -12.7% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-08-19
Q4 2022 -$88.4M -$58.7M -$49.3M -525% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$39.1M -$10.6M -$92K -0.88% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$39M -$9.28M -$1.31M -16.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$37.7M -$9.86M -$854K -9.48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$36.9M -$9.39M -$3.04M -47.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$33.8M -$10.5M -$4.36M -70.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$29.5M -$7.97M -$5.38M -208% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$24.1M -$9.01M -$5.63M -167% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$18.5M -$6.35M -$2.18M -52.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$16.3M -$6.15M -$3.23M -111% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$13.1M -$2.59M +$1.5M +36.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$14.6M -$3.38M +$1.5M +30.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$16.1M -$4.17M +$410K +8.96% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$16.5M -$2.92M +$579K +16.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$17M -$4.09M -$900K -28.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$16.1M -$4.88M -$2.08M -74.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$14.1M -$4.58M -$2.47M -117% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-17
Q3 2018 -$11.6M -$3.5M -$534K -18% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$11.1M -$3.19M +$3.48M +52.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$14.5M -$2.8M -$1.41M -102% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$13.1M -$2.11M +$1.66M +44% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 -$14.8M -$2.97M -$1.35M -83.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$13.4M -$6.67M -$5.73M -615% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$7.69M -$1.39M +$10.1M +87.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$17.8M -$3.76M +$7.31M +66% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-03
Q3 2016 -$25.1M -$1.62M +$10.3M +86.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$35.4M -$932K +$8.05M +89.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$43.4M -$11.5M +$1.82M +13.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$45.3M -$11.1M -$4.81M -76.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-03
Q3 2015 -$40.5M -$11.9M -$5.48M -85.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-03
Q2 2015 -$35M -$8.98M -$3.1M -52.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-03
Q1 2015 -$31.9M -$13.3M -$8.41M -172% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-03
Q4 2014 -$23.5M -$6.26M -$712K -12.8% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$22.8M -$6.42M -$3.06M -90.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 -$19.7M -$5.89M -$1.44M -32.4% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 -$18.3M -$4.89M -$2.5M -105% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 -$15.7M -$5.55M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-26
Q3 2013 -$3.37M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-26
Q2 2013 -$4.44M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-26
Q1 2013 -$2.39M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.